1887

Abstract

Previous studies have shown that the human polyomavirus BK (BKV) genome contains an oestrogen response element (ERE). This isolated element binds its cognate receptor in vitro and can mediate 17beta-oestradiol-induced gene expression when linked to a heterologous promoter. The roles of the ERE- and the AP-1-binding sites in oestrogen receptor-directed transcription from the complete BKV promoter/enhancer (Dunlop strain) have been examined and the effects of the general co-activator CBP and large T- and small t-antigens on oestrogen receptor-mediated transcription have been investigated. A constitutive activated oestrogen receptor stimulated BKV promoter activity in HeLa cells. Mutations in either the ERE- or the AP-1-binding sites did not impair oestrogen receptor-induced activation of the BKV Dunlop promoter, while mutations in both binding motifs almost completely abolished oestrogen receptor-induced transcription. Simultaneous expression of large T- and small t-antigens strongly activated oestrogen receptor-mediated transcription. When expressed separately, only large T-antigen moderately stimulated oestrogen receptor-mediated transcription. The stimulatory effect of large T-antigen on the activity of the oestrogen receptor is probably indirect because no physical interaction between the two proteins was detected in a two-hybrid assay. Large T-antigen abrogated the synergistic effect on transcription between this nuclear receptor and the general co-activator CBP. The findings that the BKV early proteins amplify oestrogen receptor-mediated transcription may have important biological implications in individuals with raised oestrogen concentrations.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-80-3-585
1999-03-01
2022-10-07
Loading full text...

Full text loading...

/deliver/fulltext/jgv/80/3/0800585a.html?itemId=/content/journal/jgv/10.1099/0022-1317-80-3-585&mimeType=html&fmt=ahah

References

  1. Argenton F., Bernardini S., Puttini S., Colombo L., Bortolusi M. 1996; A TGACG motif mediates growth-hormone factor-1/pituitary-transcriptional-activator-1-dependent cAMP regulation of the rainbow trout growth-hormone promoter. European Journal of Biochemistry 238:591–598
    [Google Scholar]
  2. Arthur R. R., Shah K. V., Charache P., Saral R. 1988; BK and JC virus infections in recipients of bone marrow transplants. Journal of Infectious Diseases 158:563–569
    [Google Scholar]
  3. Avantaggiati M. L., Carbone M., Graessmann A., Nakatani Y., Howard B., Levine A. S. 1996; The SV40 large T antigen and adenovirus Ela oncoproteins interact with distinct isoforms of the transcriptional co-activator p300. EMBO Journal 15:2236–2248
    [Google Scholar]
  4. Azzi A., Franci R., Bosi A., Ciappi S., Zakrzewska K., de Santis R., Laszlo D., Guidi S., Saccardi R., Vannuchi A. M., Longo G., Rossi-Ferrini P. 1994; Monitoring of polyomavirus BK viruria in bone marrow transplantation patients by DNA hybridization assay and by polymerase chain reaction: an approach to assess the relationship between BK viruria and hemorrhagic cystitis. Bone Marrow Transplantation 14:235–240
    [Google Scholar]
  5. Bannister A. J., Kouzarides T. 1996; The CBP co-activator is a histone acetyltransferase. Nature 384:641–643
    [Google Scholar]
  6. Bocquel M. T., Kumar V., Stricker C., Chambon P., Gronemeyer H. 1989; The contribution of the N- and C-terminal regions of steroid receptors to activation of transcription is both receptor and cell-specific. Nucleic Acids Research 17:2581–2595
    [Google Scholar]
  7. Borgatti M., Costanzo F., Portolani M., Vullo C., Osti L., Masi M., Brabanti-Brodano G. 1979; Evidence for reactivation of persistent infection during pregnancy and lack of congenital transmission of BK virus, a human papovavirus. Microbiologica 2:173–179
    [Google Scholar]
  8. Cassill J. A., Subramani S. 1988; The late promoter of the human papovavirus BK is contained within the early promoter enhancer region. Virology 166:175–185
    [Google Scholar]
  9. Chakraborty T., Das G. C. 1991; Proteins of the nuclear factor-1 family act as an activator of the late promoter in human polyomavirus BK in vitro . Journal of General Virology 72:1935–1942
    [Google Scholar]
  10. Chakravarti D., LaMorte V. J., Nelson M. C., Nakajima T., Schulman I. G., Juguilon H., Montminy M., Evans R. M. 1996; Role of CBP/p300 in nuclear receptor signaling. Nature 383:99–103
    [Google Scholar]
  11. Chang D., Tsai R.-T., Wang M., Ou W.-C. 1996a; Different genotypes of human polyomaviruses found in patients with autoimmune diseases in Taiwan. Journal of Medical Virology 48:204–209
    [Google Scholar]
  12. Chang D., Wang M., Ou W.-C., Lee M.-S., Ho H.-N., Tsai R.-T. 1996b; Genotypes of human polyomaviruses in urine samples of pregnant women in Taiwan. Journal of Medical Virology 48:95–101
    [Google Scholar]
  13. Clarke R., Dickson R. B., Lippman M. E. 1991; The role of steroid hormones and growth factors in the control of normal and malignant breast. In Nuclear Hormone Receptors pp 297–319 Edited by Parker M. G. London: Academic Press;
    [Google Scholar]
  14. Coleman D. V., Wolfendale M. R., Daniel R. A., Dhanjal N. K., Gardner S. D., Gibson P. E., Field A. M. 1980; A prospective study of human polyomavirus infection in pregnancy. Journal of Infectious Diseases 142:1–8
    [Google Scholar]
  15. Coleman D. V., Gardner S. D., Mulholland C., Fridiksdottir V., Porter A. A., Lilford R., Valdimarsson H. 1983; Human polyoma- virus in pregnancy. A model for the study of defence mechanisms to virus reactivation. Clinical and Experimental Immunology 53:289–293
    [Google Scholar]
  16. Damania B., Alwine J. C. 1996; TAF-like function of SV40 large T antigen. Genes and Development 10:1369–1381
    [Google Scholar]
  17. Eckner R., Ludlow J. W., Lill N. L., Oldread E., Arany Z., Modjtahedi N., DeCaprio J. A., Livingstone D. M., Morgan J. 1996; Association of p300 and CBP with simian virus 40 large T antigen. Molecular and Cellular Biology 16:3454–3464
    [Google Scholar]
  18. Kamei Y., Xu L., Heinzel T., Torchia J., Kurokawa R., Glocs B., Lin S. C., Heyman R. A., Rose D., Glass C. K., Rosenfeld M. G. 1996; A CBP integrator complex mediates transcriptional activation and AP-1 inhibition by nuclear receptors. Cell 85:403–414
    [Google Scholar]
  19. Kato S., Endoh H., Masuhiro Y., Kitamoto T., Uchiyama S., Sasaki H., Masushige S., Gotoh Y., Nishida E., Kawashima H., Metzger D., Chambon P. 1995; Activation of the estrogen receptor through phosphorylation by mitogen-activated protein kinase. Science 270:1491–1494
    [Google Scholar]
  20. Kraus W. L., Kadonaga J. T. 1998; p300 and estrogen receptor cooperatively activate transcription via differential enhancement of initiation and reinitiation. Genes and Development 12:331–342
    [Google Scholar]
  21. Kurokawa R., Kalafus D., Ogliastro M.-H., Kioussi C., Xu L., Torchia J., Rosenfeld M. G., Glass C. K. 1998; Differential use of CREB binding protein-coactivator complexes. Science 279:700–703
    [Google Scholar]
  22. Lahita R. G. 1992; Sex, age, and systemic lupus erythematosus. In Systemic Lupus Erythematosus 2nd edn pp 527–542 Edited by Lahita R. G. New York: Churchill Livingstone;
    [Google Scholar]
  23. Lukas J., Müller H., Bartkova J., Spitkovsky D., Kjerulff A. A., Jansen-Durr P., Strauss M., Bartek J. 1994; DNA tumor virus oncoproteins and retinoblastoma gene mutations share the ability to relieve the cell’s requirement for cyclin D1 function in G1. Journal of Cellular Biology 125:625–638
    [Google Scholar]
  24. Lundblad J. R., Kwok R. P. S., Laurance M. E., Harter M. L., Goodman R. H. 1995; Adenoviral E1A-associated protein p300 as a functional homologue of the transcriptional co-activator CBP. Nature 374:85–88
    [Google Scholar]
  25. Markowitz R. B., Dynan W. S. 1988; Binding of cellular proteins to the regulatory region of BK virus DNA. Journal of Virology 62:3388–3398
    [Google Scholar]
  26. Markowitz R. B., Tolbert S., Dynan W. S. 1990; Promoter evolution in BK virus: functional elements are created at sequence junctions. Journal of Virology 64:2411–2415
    [Google Scholar]
  27. Markowitz R. B., Eaton B. A., Kubik M. F., Latorra D., McGregor J. A., Dynan W. S. 1991; BK virus and JC virus shed during pregnancy have predominantly archetypal regulatory regions. Journal of Virology 65:4515–4519
    [Google Scholar]
  28. Markowitz R. B., Thompson H., Mueller J. F., Cohen J. A., Dynan W. S. 1993; Incidence of BK virus and JC virus viruria in human immunodeficiency virus-infected and -uninfected subjects. Journal of Infectious Diseases 167:13–20
    [Google Scholar]
  29. Martinez-Balbás M. A., Bannister A. J., Martin K., Haus-Seuffert P., Meisterernst M., Kouzarides T. 1998; The acetyltransferase activity of CBP stimulates transcription. EMBO Journal 17:2886–2893
    [Google Scholar]
  30. Migliaccio A., Di Domenico M., Castoria G., de Falco A., Bontempo P., Nola E., Auricchio F. 1996; Tyrosine kinase/p21 ras /MAP-kinase pathway activation by estradiol-receptor complex in MCF-7 cells. EMBO Journal 15:1292–1300
    [Google Scholar]
  31. Moens U., Sundsfjord A., Flagstad T., Traavik T. 1990; BK virus early RNA transcripts in stably transformed cells: enhanced levels induced by dibutyryl cyclic AMP, forskolin and 12-O-tetradecanoyl-phorbol-13-acetate treatment. Journal of General Virology 71:1461–1471
    [Google Scholar]
  32. Moens U., Subramaniam N., Johansen B., Johansen T., Traavik T. 1998; A steroid hormone response unit in the late leader of the noncoding control region of the human polyomavirus BK confers enhanced host cell permissivity. Journal of Virology 68:2398–2408
    [Google Scholar]
  33. Moens U., Johansen T., Johnsen J. I., Seternes O. M., Traavik T. 1995a; Noncoding control region of naturally occurring BK virus variants: sequence comparison and functional analysis. Virus Genes 10:261–275
    [Google Scholar]
  34. Moens U., Seternes O. M., Hey A. W., Silsand Y., Traavik T., Johansen B., Rekvig O. P. 1995b; In vivo expression of a single viral DNA-binding protein generates systemic lupus erythematosus-related autoimmunity to double-stranded DNA and histones. Proceedings of the National Academy of Sciences, USA 92:12393–12397
    [Google Scholar]
  35. Moens U., Seternes O. M., Johansen B., Rekvig O. P. 1997; Mechanisms of transcriptional regulation of cellular genes by SV40 large T- and small t-antigens. Virus Genes 15:135–154
    [Google Scholar]
  36. Müller E., Scheidtmann K. H. 1995; Purification and characterization of a protein kinase which is activated by SV40 large T-antigen and phosphorylates the tumor suppressor protein p53. Oncogene 10:1175–1185
    [Google Scholar]
  37. Murphy D. D., Segal M. 1997; Morphological plasticity of dendritic spines in central neurons is mediated by activation of cAMP response element binding protein. Proceedings of the National Academy of Sciences, USA 94:1482–1487
    [Google Scholar]
  38. Neuman E., Ladha M. H., Lin N., Upton T. M., Miller S. J., DiRenzo J., Pestell R. G., Hinds P. W., Dowdy S. F., Brown M., Ewen M. E. 1997; Cyclin D1 stimulation of estrogen receptor transcriptional activity independent of cdk4. Molecular and Cellular Biology 17:5338–5347
    [Google Scholar]
  39. Ogryzko V. V., Schiltz R. L., Russanova V., Howard B. H., Nakatani Y. 1996; The transcriptional coactivators p300 and CBP are histone acetyltransferases. Cell 87:953–959
    [Google Scholar]
  40. Ohkubo Y., Kishimoto T., Nakata T., Yasuda H., Endo T. 1994; SV40 large T antigen reinduces the cell cycle in terminally differentiated myotubes through inducing Cdk2, Cdc2, and their partner cyclins. Experimental Cell Research 214:270–278
    [Google Scholar]
  41. Oshima J., Steinmann K. E., Campisi J., Schlegel R. 1993; Modulation of cell growth, p34cdc2 and cyclin A levels by SV-40 large T antigen. Oncogene 8:2987–2993
    [Google Scholar]
  42. Paech K., Webb P., Kuiper G. G. J. M., Nilsson S., Gustafsson J.-Å., Kushner P. J., Scanlan T. S. 1997; Differential ligand activation of estrogen receptors ERα and ERß at AP1 sites. Science 277:1508–1510
    [Google Scholar]
  43. Parker M. G., Bakker O. 1991; Nuclear hormone receptors: concluding remarks. In NuclearHormone Receptors pp 377–395 Edited by Parker M. G. London: Academic Press;
    [Google Scholar]
  44. Peterson S. R., Gadbois D. M., Bradbury E. M., Kraemer P. M. 1994; Immortalization of human fibroblasts by SV40 large T antigen results in the reduction of cyclin D1 expression and subunit association with proliferating cell nuclear antigen and Waf. Cancer Research 55:4651–4657
    [Google Scholar]
  45. Philips A., Chalbos D., Rochefort H. 1993; Estradiol increases and anti-estrogens antagonize the growth factor-induced activator protein-1 activity in MCF7 breast cancer cells without affecting c-fos and c-jun synthesis. Journal of Biological Chemistry 268:14103–14108
    [Google Scholar]
  46. Porrás A., Bennett J., Howe A., Tokos K., Bouck N., Henglein B., Sathyamangalam S., Thimmapaya B., Rundell K. 1996; A novel simian virus 40 early-region domain mediates transactivation of the cyclin A promoter by small t antigen and is required for transformation in small t antigen-dependent assays. Journal of Virology 70:6902–6908
    [Google Scholar]
  47. Raymondjean M., Cereghini S., Yaniv M. 1988; Several distinct ′CCAAT′ box binding proteins coexist in eukaryotic cells. Proceedings of the National Academy of Sciences, USA 85:757–761
    [Google Scholar]
  48. Rekvig O. P., Moens U., Sundsfjord A., Bredholt G., Osei A., Haaheim H., Traavik T., Arnesen E., Haga H.-J. 1997; Experimental expression in mice and spontaneous expression in human SLE of polyomavirus T-antigen. A molecular basis for induction of antibodies to DNA and eukaryotic transcription factors. Journal of Clinical Investigation 99:2045–2054
    [Google Scholar]
  49. Rondinelli R. H., Haslam S. Z., Fluck M. M. 1995; The role of ovarian hormones, age and mammary gland development in polyomavirus mammary tumorigenesis. Oncogene 11:1817–1827
    [Google Scholar]
  50. Santarelli R., Tzeng Y.-J., Zimmermann C., Guhl E., Graessmann A. 1996; SV40 T-antigen induces breast cancer formation with a high efficiency in lactating and virgin WAP-SV-T transgenic animals but with a low efficiency in ovariectomized animals. Oncogene 12:495–505
    [Google Scholar]
  51. Scheidtmann K. H., Mumby M. C., Rundell K., Walter G. 1991; Dephosphorylation of simian virus 40 large T-antigen and p53 protein by protein phosphatase 2A: inhibition by small t-antigen. Molecular and Cellular Biology 11:1996–2003
    [Google Scholar]
  52. Seif I., Khoury G., Dhar R. 1979; The genome of human papovavirus BKV. Cell 18:963–977
    [Google Scholar]
  53. Seth A., Gonzalez F. A., Gupta S., Raden D. L., Davis R. J. 1992; Signal transduction within the nucleus by mitogen-activated protein kinase. Journal of Biological Chemistry 267:24796–24804
    [Google Scholar]
  54. Shah K., Daniel R., Madden D., Stago S. 1980; Serological investigation of BK papovavirus infections in pregnant women and their offspring. Infection & Immunity 30:29–35
    [Google Scholar]
  55. Shikama N., Lyon J., La Thangue N. B. 1997; The p300/CBP family: integrating signals with transcription factors and chromatin. Trends in Cell Biology 7:230–236
    [Google Scholar]
  56. Shivakumar C. V., Das G. C. 1996; Interaction of human polyomavirus BK with the tumor-suppressor protein p53. Oncogene 13:323–332
    [Google Scholar]
  57. Simmons D. T., Upson R. H., Wun-Kim K., Young W. 1993; Biochemical analysis of mutants with changes in the origin-binding domain of simian virus 40 tumor antigen. Journal of Virology 67:4227–4236
    [Google Scholar]
  58. Smith C. L., Onate S. A., Tsai M.-J., O’Malley B. W. 1996; CREB binding protein acts synergistically with steroid receptor coactivator-1 to enhance steroid receptor-dependent transcription. Proceedings of the National Academy of Sciences, USA 93:8884–8888
    [Google Scholar]
  59. Sontag E., Fedorov S., Kamibayashi C., Robbins D., Cobb M., Mumby M. 1993; The interaction of SV40 small tumor antigen with protein phosphatase 2A stimulates the MAP kinase pathway and induces cell proliferation. Cell 75:887–897
    [Google Scholar]
  60. Sontag E., Sontag J.-M., Garcia A. 1997; Protein phosphatase 2A is a critical regulator of protein kinase C Z signaling targeted by SV40 small t to promote cell growth and nf-k b activation. EMBO Journal 16:5662–5671
    [Google Scholar]
  61. Sukovich D. A., Mukherjee R., Benfield P. A. 1994; A novel, cell-type specific mechanism for estrogen receptor-mediated gene activation in the absence of an estrogen-responsive element. Molecular and Cellular Biology 14:7134–7143
    [Google Scholar]
  62. Sundsfjord A., Flagstad T., Flø R., Spein A. R., Pedersen M., Permin H., Julsrud J., Traavik T. 1993; BK and JC viruses in human immunodeficiency type 1-infected persons: prevalence, excretion, viremia, and viral regulatory regions. Journal of Infectious Diseases 169:485–490
    [Google Scholar]
  63. Tavis J. E., Walker D. L., Gardner S. D., Frisque R. J. 1989; Nucleotide sequence of the human polyomavirus AS virus, an antigenic variant of BK virus. Journal of Virology 63:901–911
    [Google Scholar]
  64. Trowbridge J. M., Rogatsky I., Garabedian M. J. 1997; Regulation of estrogen receptor transcriptional enhancement by the cyclin A/Cdk2 complex. Proceedings of the National Academy of Sciences, USA 94:10132–10137
    [Google Scholar]
  65. Wang H., Peters G. A., Zeng X., Tang M., Ip W., Khan S. A. 1995; Yeast two-hybrid system demonstrates that estrogen receptor dimerization is ligand-dependent in vivo . Journal of Biological Chemistry 270:23322–23329
    [Google Scholar]
  66. Weisz A., Rosales R. 1990; Identification of an estrogen response element upstream of the human c-fos gene that binds the estrogen receptor and the AP-1 transcription factor. Nucleic Acids Research 18:5097–5106
    [Google Scholar]
  67. Weisz A., Cicatiello L., Persico E., Scalona M., Bresciani F. 1990; Estrogen stimulates transcription of c-jun protooncogene. Molecular Endocrinology 4:1041–1050
    [Google Scholar]
  68. White R., Sjøberg M., Kalkhoven E., Parker M. G. 1997; Ligand-independent activation of the oestrogen receptor by mutation of a conserved tyrosine. EMBO Journal 16:1427–1435
    [Google Scholar]
  69. Wilding G., Lippman M. E., Gelmann E. P. 1988; Effects of steroid hormones and peptide growth factors on protooncogene c-fos expression in human breast cancer cells. Cancer Research 48:802–805
    [Google Scholar]
  70. Yoshiike K., Takemoto K. K. 1986; Studies with BK virus and monkey lymphotropic papovavirus. In The Papovaviridae vol 1 pp 295–326 Edited by Salzman N. P. New York: Plenum;
    [Google Scholar]
  71. Yu C.-L., Diggers P., Barrera-Hernandez G., Nunez S. B., Segars J. H., Cheng S.-Y. 1997; The tumor suppressor p53 is a negative regulator of estrogen receptor signaling pathways. Biochemical and Biophysical Research Communications 239:617–620
    [Google Scholar]
  72. Zhou Y., Watters J. J., Dorsa D. M. 1996; Estrogen rapidly induces the phosphorylation of the cAMP response element binding protein in rat brain. Endocrinology 137:2163–2166
    [Google Scholar]
  73. Zwijsen R. M. L., Wientjes E., Klompmaker R., van der Sman J., Bernards R., Michalides R. J. A. M. 1997; activation of estrogen receptor by cyclin D1. Cell 88:405–415
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-80-3-585
Loading
/content/journal/jgv/10.1099/0022-1317-80-3-585
Loading

Data & Media loading...

Most cited this month Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error